News

Biodesix Strengthens Its Partnership with Bio-Rad for Advanced Diagnostics

Biodesix Strengthens Its Partnership with Bio-Rad for Advanced Diagnostics

Biodesix Expands Partnership with Bio-Rad Laboratories

Biodesix, Inc. (NYSE: BDSX), a pioneering name in diagnostics solutions, is set to enhance its offerings significantly through a new partnership agreement with Bio-Rad Laboratories. This strategic collaboration focuses on developing in vitro diagnostic (IVD) assays that leverage the advanced capabilities of Bio-Rad's Droplet Digital™ PCR (ddPCR™) technology.

Innovative Technologies for Oncology Applications

The initial focus under this expanded agreement will be the development of assays aimed at the early and sensitive detection of genomic markers in oncology. One of the key assays to be validated is Bio-Rad's ddPLEX ESR1 Mutation Detection Assay. This particular test is becoming increasingly crucial in the assessment of HR+/HER2- advanced breast cancer patients, especially in light of the groundbreaking benefits offered by new oral therapies known as selective estrogen receptor degraders (SERDs).

Clinical Validation and Patient Outcomes

Once the ESR1 assay undergoes clinical validation, it will be readily available to both biopharma clients for therapeutic advancements and clinical customers for ongoing cancer treatment monitoring. A significant goal for Biodesix is to seek reimbursement for this assay through the Centers for Medicare & Medicaid Services (CMS), which would enhance accessibility for patients requiring detailed genomic insights.

Leadership Insights on Partnership Impact

Scott Hutton, CEO of Biodesix, expressed his excitement regarding the partnership, stating, "The emergence of ESR1 mutations as biomarkers for breast cancer has had a significant impact on the oncology market, leading to an increased global demand for rapid, sensitive assays." He highlighted how this alliance not only bolsters their operating capability but also opens new avenues for personalized, data-driven medicine.

Long-Standing Relationship Yielding Results

Steve Kulisch, VP of Product Management at Bio-Rad Laboratories, noted that their ongoing relationship has been fruitful in delivering effective clinical applications of ddPCR technology, especially in non-small cell lung cancer diagnostics. He emphasized that further validation of the ddPLEX ESR1 kits will expand both companies' contributions to clinical diagnostics and increase access to vital biomarker detection.

Upcoming Events and Knowledge Sharing

At the upcoming AMP conference, significant opportunities will arise for Biodesix and Bio-Rad to present their respective research and development visions and commercial strategies. Attendees can look forward to detailed insights during their corporate workshops scheduled on November 12.

  • Bio-Rad Laboratories Corporate Workshop, Nov 12, at 8:00 am ET
  • Biodesix Corporate Workshop, Nov 12, at 4:00 pm ET

About Biodesix and Its Impact on Diagnostics

Biodesix's mission is to enhance clinical care and patient outcomes through innovative diagnostic solutions. Their diagnostic tests, such as Nodify Lung® for nodule risk assessment and IQLung® for cancer treatment guidance, exemplify their commitment to facilitating personalized medical care. Through these developments, Biodesix is equipped to provide essential capabilities that support the advancement of diagnostic tests and therapeutics in the life sciences sector.

Contacting Biodesix

For further information, individuals may reach out to the company’s contacts:

Media Inquiries:
Natalie St. Denis, Director of Corporate Communications
Email: natalie.stdenis@biodesix.com
Phone: (720) 925-9285

Investor Relations:
Chris Brinzey, Partner, ICR
Email: chris.brinzey@icrhealthcare.com
Phone: (339) 970-2843

Frequently Asked Questions

What is the purpose of the collaboration between Biodesix and Bio-Rad?

The collaboration aims to develop highly sensitive IVD assays for oncology applications using Bio-Rad's advanced PCR technology.

What is the significance of the ESR1 Mutation Detection Assay?

This assay enables sensitive detection and quantification of ESR1 mutations, which are vital in treating advanced breast cancer.

Where will the ESR1 assay be available?

Once validated, the ESR1 assay will be offered at Biodesix' accredited CLIA-CAP laboratory for various clinical and biopharma customers.

How will the partnership benefit patients?

The collaboration will enhance access to precise diagnostics, ultimately improving patient care and treatment outcomes in oncology.

What upcoming events will showcase this partnership's innovations?

Biodesix and Bio-Rad will present at the AMP conference, offering details on their R&D initiatives and commercial plans.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Equitable Bank Bumps Rates Amid Market Shuffle

Updated Category News Views 57

Equitable Bank Dials Up Its Prime Rate Equitable Bank's taken a step that every borrower and investor out there can't ignore: they've hiked their prime lending rate by 25 basis points, pushing it up to 4.70% from 4.45%. Now, any old-timer in the trading arena knows that when banks shift their rates, it's not just numbers on paper—it ripples across the landscape, from...

Continue Reading
HiTHIUM Powers Up Australia's Energy Storage Future

Updated Category News Views 85

Just imagine, folks, a slice of the energy world reshaping right under our feet in good ol' Australia. That's the buzz HiTHIUM sparked at All Energy Australia as they showcased their fancy ?Power 6.9MWh, 8-hour long-duration battery storage system (BESS). It wasn’t just about the tech superiority but the strategic planting of stakes in the local energy market....

Continue Reading
Bloomberg Law Integrates Docket Data with AI Platform

Updated Category News Views 24

Bloomberg Law's Game-Changer for Legal Pros Here's something that'll make legal eagles perk up on this fine day: Bloomberg Law has rolled out a connector for Claude, marrying court dockets and litigation smarts to AI. Let's face it, the legal world always runs on precision and timing above all. So when an integration like this drops, it ain’t just a memo on the office...

Continue Reading
Dietary Supplements Market Soars with 7.7% CAGR Growth

Updated Category News Views 104

You know, there's a gold rush happening right now, and it's not for your traditional bullion. It's vitamins, minerals, and all that shiny array of supplements making waves in the market. By 2031, we're talking about a $299.57 billion industry, fueled by a hefty 7.7% CAGR. What's cooking here? Let's delve deeper, my friend. Asia Pacific: A Rising Star Over in the Asia...

Continue Reading
Sage Longboat Key Condos Battle Florida's Marine Climate

Updated Category News Views 29

Building Resilience on Florida's Shores If you've ever had your eyes on some beachfront real estate down in Florida, you'd know it's not all sandy beaches and sunsets. It's a constant battle against the elements, my friends. The Sage Longboat Key condominiums in Sarasota have taken this challenge head-on with some serious innovation. The Condominium Dream Sitting pretty...

Continue Reading
Spotting Alzheimer's: Holiday Visits Might Reveal More

Updated Category News Views 34

The Unspoken Truth of Holiday Reunions Is there any better barometer than a holiday visit to gauge how your parents are truly doing? Most of us are zooming in, lugging our baggage through the front door and finding Dad telling the same old story not once, not twice, but three solid times at the table. Then there’s Mom, fumbling her way through that pie recipe she could...

Continue Reading
MUFG Debuts VAM for Streamlined Treasury Ops

Updated Category News Views 34

MUFG's Bold Move into Digital Liquidity Alright, let's dive into MUFG's latest shake-up, and boy, it's no small fry. This Japanese financial giant's got its eyes set on transforming how businesses handle their cash with what they're calling Virtual Account Management, or VAM - a fancy name for a digital liquidity tool that's looking to cut the clutter of multiple bank...

Continue Reading
BTQ's MIMIQ: A Quantum Leap for 35,000 Developers

Updated Category News Views 17

Breaking Barriers in Quantum Emulation If you think the quantum computing game is all about hardware, then you're missing half the picture. Enter BTQ Technologies, crash-landing into the scene by throwing open the doors of their MIMIQ emulator to a crowd of over 35,000 quantum developers through qBraid. This ain't just an upgrade—it's a seismic shift. More qubits, more...

Continue Reading
West Fraser Tackles Grim Quarter: Indefinite Mill Closures

Updated Category News Views 176

Bracing For Impact: The Tough Truth About West Fraser's Recent Moves Things are looking a bit bleak over at West Fraser Timber Co. They've just dropped their Q3 2026 results, ringing the bell with a hefty $80 million loss. As if that wasn't enough, the company's decided to indefinitely curtail a couple of mills—one in Lanett, Alabama and the other in Leola, Arkansas....

Continue Reading
Evotec SE to Release Q3 Results: What to Expect

Updated Category News Views 72

Anticipation Builds Around Evotec's Q3 2026 Results It's that time again when everyone's tightening their belts in anticipation of another earnings feed. On November 5, Evotec SE is dropping their results for the first nine months of this whirlwind year. Right out of Germany, Hamburg, they're gearing up for a webcast and conference call where all eyes, or should I say...

Continue Reading

Top 5 Most Recently Viewed Articles

Jay O'Brien Joins Jones Walker as Partner in Litigation Group

Updated Category News Views 181

Jones Walker Welcomes New Litigation Partner Jay O'Brien Jones Walker LLP recently announced the addition of Jay O'Brien as a partner in its renowned Litigation Practice Group. As a seasoned litigator, O'Brien brings a wealth of knowledge and expertise that will greatly benefit the firm and its clients. Exceptional Litigation Expertise Jay O'Brien specializes in...

Continue Reading
Empowering Texas Voters: Toby Cole on Voting Rights for All

Updated Category News Views 212

Empowering Voters with Special Needs Toby Cole, a passionate advocate and attorney, is shining a light on the voting rights of Texans with special needs and limited English proficiency. As early voting approaches, Cole emphasizes the importance of understanding these rights, ensuring that everyone can exercise their right to vote with assistance when necessary. Importance...

Continue Reading
Worksport Ltd. Showcases Exceptional Q1 Growth with New Strategies

Updated Category News Views 159

Exceptional Financial Performance in Q1 2025 Worksport Ltd. (NASDAQ: WKSP) recently reported an impressive start to 2025, with a remarkable increase in revenue and a significant boost in gross margins. The innovative manufacturer of hybrid and clean energy solutions is on track to achieve significant financial milestones this fiscal year, setting a path toward sustained...

Continue Reading
Anthony Scaramucci's Insight on Solana's Surge Over Ethereum

Updated Category News Views 62

Insight into Solana's Growth Potential SkyBridge Capital founder Anthony Scaramucci has sparked renewed interest in the ongoing debate between Solana and Ethereum, proclaiming that Solana might soon surpass Ethereum in terms of market value. This statement comes at a time when Solana's ecosystem is rapidly expanding, driven by increased developer activity and rising user...

Continue Reading
Impactful Legacy: How a $20 Million Gift Transforms KCU

Updated Category News Views 331

Historic Donation Ignites Growth at Kansas City University Kansas City University (KCU) has received an extraordinary gift of over $20 million from the estate of Paul W. Dybedal, DO, and his wife, Mary Louise Dybedal. This landmark contribution, the largest from an individual in the institution's history, exemplifies the Dybedals' unwavering dedication to the advancement...

Continue Reading